دورية أكاديمية
أعرض في EDS

Parkinson's Disease: Available Clinical and Promising Omics Tests for Diagnostics, Disease Risk Assessment, and Pharmacotherapy Personalization.

التفاصيل البيبلوغرافية
العنوان: Parkinson's Disease: Available Clinical and Promising Omics Tests for Diagnostics, Disease Risk Assessment, and Pharmacotherapy Personalization.
المؤلفون: Trifonova OP; Laboratory of mass spectrometry-based metabolomics diagnostics, Institute of Biomedical Chemistry, 10 building 8, Pogodinskaya street, 119121 Moscow, Russia., Maslov DL; Laboratory of mass spectrometry-based metabolomics diagnostics, Institute of Biomedical Chemistry, 10 building 8, Pogodinskaya street, 119121 Moscow, Russia., Balashova EE; Laboratory of mass spectrometry-based metabolomics diagnostics, Institute of Biomedical Chemistry, 10 building 8, Pogodinskaya street, 119121 Moscow, Russia., Urazgildeeva GR; 5th Neurological Department (Department of Neurogenetics), Research Centre of Neurology, Volokolamskoe shosse, 80, 125367 Moscow, Russia., Abaimov DA; 5th Neurological Department (Department of Neurogenetics), Research Centre of Neurology, Volokolamskoe shosse, 80, 125367 Moscow, Russia., Fedotova EY; 5th Neurological Department (Department of Neurogenetics), Research Centre of Neurology, Volokolamskoe shosse, 80, 125367 Moscow, Russia., Poleschuk VV; 5th Neurological Department (Department of Neurogenetics), Research Centre of Neurology, Volokolamskoe shosse, 80, 125367 Moscow, Russia., Illarioshkin SN; 5th Neurological Department (Department of Neurogenetics), Research Centre of Neurology, Volokolamskoe shosse, 80, 125367 Moscow, Russia., Lokhov PG; Laboratory of mass spectrometry-based metabolomics diagnostics, Institute of Biomedical Chemistry, 10 building 8, Pogodinskaya street, 119121 Moscow, Russia.
المصدر: Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2020 May 25; Vol. 10 (5). Date of Electronic Publication: 2020 May 25.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101658402 Publication Model: Electronic Cited Medium: Print ISSN: 2075-4418 (Print) Linking ISSN: 20754418 NLM ISO Abbreviation: Diagnostics (Basel) Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI AG, [2011]-
مستخلص: Parkinson's disease is the second most frequent neurodegenerative disease, representing a significant medical and socio-economic problem. Modern medicine still has no answer to the question of why Parkinson's disease develops and whether it is possible to develop an effective system of prevention. Therefore, active work is currently underway to find ways to assess the risks of the disease, as well as a means to extend the life of patients and improve its quality. Modern studies aim to create a method of assessing the risk of occurrence of Parkinson's disease (PD), to search for the specific ways of correction of biochemical disorders occurring in the prodromal stage of Parkinson's disease, and to personalize approaches to antiparkinsonian pharmacotherapy. In this review, we summarized all available clinically approved tests and techniques for PD diagnostics. Then, we reviewed major improvements and recent advancements in genomics, transcriptomics, and proteomics studies and application of metabolomics in PD research, and discussed the major metabolomics findings for diagnostics and therapy of the disease.
References: Biomed Khim. 2017 Mar;63(2):115-123. (PMID: 28414282)
Front Aging Neurosci. 2018 May 29;10:157. (PMID: 29896099)
Sci Rep. 2019 Apr 16;9(1):6151. (PMID: 30992490)
J Parkinsons Dis. 2017;7(1):65-77. (PMID: 28222539)
PLoS One. 2012;7(2):e32383. (PMID: 22384236)
Front Aging Neurosci. 2018 May 15;10:136. (PMID: 29867446)
Continuum (Minneap Minn). 2013 Oct;19(5 Movement Disorders):1189-212. (PMID: 24092286)
Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S31-3. (PMID: 22166447)
Parkinsonism Relat Disord. 2017 Sep;42:1-11. (PMID: 28647434)
Int J Gen Med. 2010 Jul 21;3:181-5. (PMID: 20689691)
Neurosci Bull. 2014 Feb;30(1):134-40. (PMID: 24136244)
J Neurol. 2000 Apr;247 Suppl 2:II11-8. (PMID: 10991656)
Mov Disord. 2018 Nov;33(11):1792-1799. (PMID: 30423212)
Zhonghua Yi Xue Za Zhi. 2013 Jul 2;93(25):1944-7. (PMID: 24169240)
Mov Disord. 2011 Apr;26(5):775-83. (PMID: 21484865)
Arq Bras Oftalmol. 2014 Aug;77(4):238-42. (PMID: 25410176)
Front Neurol. 2013 Jan 21;3:187. (PMID: 23346074)
FASEB J. 2006 Mar;20(3):419-25. (PMID: 16507759)
Mov Disord. 2014 Nov;29(13):1574-81. (PMID: 25308960)
Neurosci Lett. 2010 Aug 9;480(1):78-82. (PMID: 20540987)
Arch Neurol. 2009 Dec;66(12):1460-8. (PMID: 19822770)
Neurol Res. 2013 Oct;35(8):873-8. (PMID: 23676350)
Neurogenetics. 2010 Jul;11(3):305-12. (PMID: 20013014)
Neurosci Lett. 2003 Jan 16;336(2):105-8. (PMID: 12499051)
Int Rev Neurobiol. 2018;141:131-172. (PMID: 30314595)
Sensors (Basel). 2015 Aug 31;15(9):21710-45. (PMID: 26404288)
Mov Disord. 2017 Jun;32(6):865-873. (PMID: 28429825)
Ann Neurol. 2003 Jul;54(1):93-101. (PMID: 12838524)
N Engl J Med. 2009 Oct 22;361(17):1651-61. (PMID: 19846850)
Neurol Sci. 2020 Apr;41(4):893-901. (PMID: 31828678)
J Neurochem. 2002 Jun;81(5):954-60. (PMID: 12065607)
Front Neurol. 2019 Feb 12;10:100. (PMID: 30809189)
Parkinsons Dis. 2018 Jul 11;2018:3201308. (PMID: 30123489)
Neuroimage Clin. 2016 Jan 12;11:68-72. (PMID: 26909330)
J Magn Reson Imaging. 2017 Aug;46(2):528-536. (PMID: 27859983)
J Neural Transm (Vienna). 2017 Jul;124(7):869-879. (PMID: 28451942)
AJNR Am J Neuroradiol. 2015 Nov;36(11):2010-6. (PMID: 26294646)
J Ultrasound Med. 2016 Jan;35(1):17-23. (PMID: 26589647)
Neurology. 1992 Aug;42(8):1554-60. (PMID: 1641153)
Eur J Neurol. 2013 Jan;20(1):16-34. (PMID: 23279440)
Mol Cell Probes. 2016 Dec;30(6):386-396. (PMID: 27818248)
Int J Mol Sci. 2020 Jan 15;21(2):. (PMID: 31952343)
JAMA Neurol. 2013 Oct;70(10):1277-87. (PMID: 23979011)
Mov Disord. 2013 Apr;28(4):455-9. (PMID: 23115064)
Mov Disord. 2019 Feb;34(2):246-254. (PMID: 30557454)
Lancet Neurol. 2019 Dec;18(12):1091-1102. (PMID: 31701892)
Biomed Rep. 2016 Jan;4(1):122-126. (PMID: 26870348)
Front Neurol. 2019 Dec 17;10:1328. (PMID: 31920948)
Metabolites. 2017 Aug 11;7(3):. (PMID: 28800113)
Mov Disord. 2006 Oct;21(10):1763-5. (PMID: 16874758)
Rapid Commun Mass Spectrom. 2007;21(3):421-8. (PMID: 17206744)
Neurol Genet. 2016 Sep 08;2(5):e104. (PMID: 27648471)
Eur J Neurol. 2018 Jan;25(1):41-58. (PMID: 28803444)
Arch Neurol. 2002 Jun;59(6):999-1005. (PMID: 12056937)
Mol Neurodegener. 2019 Aug 29;14(1):36. (PMID: 31464647)
Ann Neurol. 2011 Mar;69(3):570-80. (PMID: 21400565)
Mov Disord Clin Pract. 2018 Feb 22;5(2):131-140. (PMID: 30363419)
Mov Disord. 2018 Oct;33(10):1601-1608. (PMID: 30145797)
Mov Disord Clin Pract. 2017 Jun 30;4(5):755-762. (PMID: 30363372)
Mov Disord. 2007 Nov 15;22(15):2274-8. (PMID: 17914726)
Radiology. 2014 Jun;271(3):831-8. (PMID: 24601752)
Sci Rep. 2012;2:954. (PMID: 23233873)
Mov Disord. 2015 Oct;30(12):1600-11. (PMID: 26474317)
Ultraschall Med. 2006 Feb;27(1):12-9. (PMID: 16470475)
Mov Disord. 2005 Mar;20(3):383-5. (PMID: 15486999)
Lancet. 2015 Aug 29;386(9996):896-912. (PMID: 25904081)
Mov Disord. 2015 Oct;30(12):1591-601. (PMID: 26474316)
J Pers Med. 2018 Sep 05;8(3):. (PMID: 30189667)
PLoS One. 2018 Jan 5;13(1):e0190072. (PMID: 29304050)
Eur Neurol. 2007;58(2):78-83. (PMID: 17565220)
Brain Res. 2003 Aug 29;982(2):137-45. (PMID: 12915249)
BMJ Open. 2017 Dec 14;7(12):e016904. (PMID: 29247084)
Eur J Neurol. 2014 May;21(5):802-7. (PMID: 23551560)
Ophthalmic Physiol Opt. 2015 Jul;35(4):352-76. (PMID: 26094831)
Brain. 1996 Apr;119 ( Pt 2):585-91. (PMID: 8800950)
Biomed Khim. 2015 Jan-Feb;61(1):7-18. (PMID: 25762595)
Eur Neurol. 2000;43(2):95-101. (PMID: 10686467)
Sci Transl Med. 2012 Feb 15;4(121):121ra20. (PMID: 22344688)
Parkinsons Dis. 2015;2015:294396. (PMID: 26483988)
Mov Disord. 2002 Jul;17(4):795-8. (PMID: 12210878)
Eur J Cancer Prev. 2013 Jul;22(4):335-41. (PMID: 23212094)
Biomed Res Int. 2019 May 19;2019:3753786. (PMID: 31236405)
JAMA. 2020 Feb 11;323(6):548-560. (PMID: 32044947)
Neurology. 2015 Mar 3;84(9):880-7. (PMID: 25653295)
Sao Paulo Med J. 2006 May 4;124(3):168-75. (PMID: 17119698)
J Parkinsons Dis. 2019;9(2):427-435. (PMID: 30958314)
Nat Rev Neurol. 2014 Dec;10(12):708-22. (PMID: 25385334)
OMICS. 2013 Nov;17(11):550-9. (PMID: 24044364)
Eur Rev Med Pharmacol Sci. 2015 Dec;19(23):4603-9. (PMID: 26698258)
Parkinsonism Relat Disord. 2017 Jul;40:1-10. (PMID: 28284903)
Analyst. 2010 Nov;135(11):2970-8. (PMID: 20856980)
Brain. 2008 Feb;131(Pt 2):389-96. (PMID: 18222993)
Drug Discov Today. 2016 Jan;21(1):103-110. (PMID: 26220091)
Parkinsonism Relat Disord. 2007;13 Suppl 3:S421-4. (PMID: 18267275)
Cold Spring Harb Perspect Med. 2012 Jan;2(1):a008888. (PMID: 22315721)
Nat Rev Neurol. 2016 Oct 27;12(11):622-634. (PMID: 27786242)
Ann Neurol. 2012 Dec;72(6):893-901. (PMID: 23071076)
Pharmacol Res. 2001 May;43(5):423-7. (PMID: 11394933)
Med Clin North Am. 2019 Mar;103(2):337-350. (PMID: 30704685)
J Neurol Neurosurg Psychiatry. 1995 Dec;59(6):597-600. (PMID: 7500096)
Mov Disord. 2015 Oct;30(12):1648-56. (PMID: 26207725)
J Neural Transm (Vienna). 2017 Aug;124(8):901-905. (PMID: 28150045)
J Neurochem. 2016 Oct;139 Suppl 1:318-324. (PMID: 27401947)
FASEB J. 2011 Dec;25(12):4127-37. (PMID: 21865317)
Clin Otolaryngol. 2017 Aug;42(4):837-843. (PMID: 28004533)
PLoS One. 2014 Sep 09;9(9):e105343. (PMID: 25202985)
Eur J Neurol. 2013 Jan;20(1):102-8. (PMID: 22852790)
Lancet Neurol. 2008 Nov;7(11):1044-55. (PMID: 18940694)
Transl Neurodegener. 2017 Mar 28;6:8. (PMID: 28360997)
Int Rev Neurobiol. 2018;143:179-212. (PMID: 30473195)
Neuroimaging Clin N Am. 2010 Feb;20(1):111-23. (PMID: 19959023)
J Parkinsons Dis. 2013;3(1):19-29. (PMID: 23938308)
Drug Discov Today. 2013 Feb;18(3-4):155-62. (PMID: 22982303)
Mov Disord. 2012 Apr 15;27(5):656-65. (PMID: 22508284)
Neurosci Lett. 2013 Sep 13;551:75-8. (PMID: 23880019)
Neurobiol Dis. 2019 Apr;124:230-239. (PMID: 30448284)
Mov Disord. 2019 Oct;34(10):1464-1470. (PMID: 31412427)
Brain. 2012 Jun;135(Pt 6):1900-13. (PMID: 22451506)
Mov Disord. 2015 Jul;30(8):1068-76. (PMID: 25773707)
معلومات مُعتمدة: 19-29-01125\19 Russian Foundation for Basic Research
فهرسة مساهمة: Keywords: Parkinson's disease; biomarker; clinical test; diagnostics; metabolomics; pharmacotherapy personalization
تواريخ الأحداث: Date Created: 20200530 Latest Revision: 20231111
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC7277996
DOI: 10.3390/diagnostics10050339
PMID: 32466249
قاعدة البيانات: MEDLINE
الوصف
تدمد:2075-4418
DOI:10.3390/diagnostics10050339